{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:34:16Z","timestamp":1786739656956,"version":"build-2736575974"},"reference-count":72,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:p>JOURNAL\/nrgr\/04.03\/01300535-202304000-00028\/figure1\/v\/2026-08-03T181711Z\/r\/image-tiff<\/jats:p>\n                  <jats:p>\n                    Sphingosine-1-phosphate receptor (S1PR) signaling regulates diverse pathophysiological processes in the central nervous system. The role of S1PR signaling in neurodegenerative conditions is still largely unidentified. Siponimod is a specific modulator of S1P1 and S1P5 receptors, an immunosuppressant drug for managing secondary progressive multiple sclerosis. We investigated its neuroprotective properties\n                    <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                    on the retina and the brain in an optic nerve injury model induced by a chronic increase in intraocular pressure or acute N-methyl-D-aspartate excitotoxicity. Neuronal-specific deletion of sphingosine-1-phosphate receptor (S1PR1) was carried out by expressing AAV-PHP.eB-Cre recombinase under Syn1 promoter in S1PR1\n                    <jats:italic toggle=\"yes\">flox\/flox<\/jats:italic>\n                    mice to define the role of S1PR1 in neurons. Inner retinal electrophysiological responses, along with histological and immunofluorescence analysis of the retina and optic nerve tissues, indicated significant neuroprotective effects of siponimod when administered orally via diet in chronic and acute optic nerve injury models. Further, siponimod treatment showed significant protection against trans-neuronal degenerative changes in the higher visual center of the brain induced by optic nerve injury. Siponimod treatment also reduced microglial activation and reactive gliosis along the visual pathway. Our results showed that siponimod markedly upregulated neuroprotective Akt and Erk1\/2 activation in the retina and the brain. Neuronal-specific deletion of S1PR1 enhanced retinal and dorsolateral geniculate nucleus degenerative changes in a chronic optic nerve injury condition and attenuated protective effects of siponimod. In summary, our data demonstrated that S1PR1 signaling plays a vital role in the retinal ganglion cell and dorsolateral geniculate nucleus neuronal survival in experimental glaucoma, and siponimod exerts direct neuroprotective effects through S1PR1 in neurons in the central nervous system independent of its peripheral immuno-modulatory effects. Our findings suggest that neuronal S1PR1 is a neuroprotective therapeutic target and its modulation by siponimod has positive implications in glaucoma conditions.\n                  <\/jats:p>","DOI":"10.4103\/1673-5374.344952","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T01:38:15Z","timestamp":1652060295000},"page":"840-848","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":25,"title":["Siponimod exerts neuroprotective effects on the retina and higher visual pathway through neuronal S1PR1 in experimental glaucoma"],"prefix":"10.4103","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0997-0196","authenticated-orcid":false,"given":"Devaraj","family":"Basavarajappa","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0202-7843","authenticated-orcid":false,"given":"Vivek","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Chitranshi","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshana Vander","family":"Wall","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashi","family":"Rajput","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanishka","family":"Pushpitha","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samridhi","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Mirzaei","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Klistorner","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart L.","family":"Graham","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"R1-20260803","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1007\/s12035-020-01948-9","article-title":"Caveolin-1 ablation imparts partial protection against inner retinal injury in experimental glaucoma and reduces apoptotic activation","volume":"57","author":"Abbasi","year":"2020","journal-title":"Mol Neurobiol"},{"key":"R2-20260803","doi-asserted-by":"crossref","first-page":"6154","DOI":"10.7150\/thno.55472","article-title":"Inner retinal injury in experimental glaucoma is prevented upon AAV mediated Shp2 silencing in a caveolin dependent manner","volume":"11","author":"Abbasi","year":"2021","journal-title":"Theranostics"},{"key":"R3-20260803","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.phrs.2016.07.042","article-title":"Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat","volume":"111","author":"Amadio","year":"2016","journal-title":"Pharmacol Res"},{"key":"R4-20260803","doi-asserted-by":"crossref","first-page":"101817","DOI":"10.1016\/j.pneurobio.2020.101817","article-title":"Glaucoma as a neurodegenerative disease caused by intrinsic vulnerability factors","volume":"193","author":"Artero-Castro","year":"2020","journal-title":"Prog Neurobiol"},{"key":"R5-20260803","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","article-title":"Multiple sclerosis:mechanisms and immunotherapy","volume":"97","author":"Baecher-Allan","year":"2018","journal-title":"Neuron"},{"key":"R6-20260803","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/cells8010024","article-title":"Mechanism of siponimod:anti-inflammatory and neuroprotective mode of action","volume":"8","author":"Behrangi","year":"2019","journal-title":"Cells"},{"key":"R7-20260803","doi-asserted-by":"crossref","first-page":"e10291","DOI":"10.15252\/emmm.201910291","article-title":"Mouse Nr2f1 haploinsufficiency unveils new pathological mechanisms of a human optic atrophy syndrome","volume":"11","author":"Bertacchi","year":"2019","journal-title":"EMBO Mol Med"},{"key":"R8-20260803","first-page":"20552173211049168","article-title":"Siponimod (BAF312) penetrates distributes and acts in the central nervous system:Preclinical insights","volume":"7","author":"Bigaud","year":"2021","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"R9-20260803","doi-asserted-by":"crossref","first-page":"eaar5551","DOI":"10.1126\/science.aar5551","article-title":"Sphingosine 1-phosphate:Lipid signaling in pathology and therapy","volume":"366","author":"Cartier","year":"2019","journal-title":"Science"},{"key":"R10-20260803","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nn.4593","article-title":"Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems","volume":"20","author":"Chan","year":"2017","journal-title":"Nat Neurosci"},{"key":"R11-20260803","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.3390\/cells10113217","article-title":"Signaling through the S1P-S1PR axis in the gut the immune and the central nervous system in multiple sclerosis:implication for pathogenesis and treatment","volume":"10","author":"Chatzikonstantinou","year":"2021","journal-title":"Cells"},{"key":"R12-20260803","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00401-011-0807-1","article-title":"The optic nerve head is the site of axonal transport disruption axonal cytoskeleton damage and putative axonal regeneration failure in a rat model of glaucoma","volume":"121","author":"Chidlow","year":"2011","journal-title":"Acta Neuropathol"},{"key":"R13-20260803","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ymthe.2018.09.019","article-title":"Loss of Shp2 rescues BDNF\/TrkB signaling and contributes to improved retinal ganglion cell neuroprotection","volume":"27","author":"Chitranshi","year":"2019","journal-title":"Mol Ther"},{"key":"R14-20260803","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1073\/pnas.1014154108","article-title":"FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation","volume":"108","author":"Choi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R15-20260803","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev-pharmtox-010818-021358","article-title":"Fingolimod:lessons learned and new opportunities for treating multiple sclerosis and other disorders","volume":"59","author":"Chun","year":"2019","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R16-20260803","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3389\/fimmu.2020.00635","article-title":"Siponimod (BAF312) activates Nrf2 while hampering NF\u03baB in human astrocytes and protects from astrocyte-induced neurodegeneration","volume":"11","author":"Colombo","year":"2020","journal-title":"Front Immunol"},{"key":"R17-20260803","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.expneurol.2019.01.015","article-title":"Retinoid x receptor modulation protects against ER stress response and rescues glaucoma phenotypes in adult mice","volume":"314","author":"Dheer","year":"2019","journal-title":"Exp Neurol"},{"key":"R19-20260803","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/14656566.2018.1551363","article-title":"Siponimod for the treatment of secondary progressive multiple sclerosis","volume":"20","author":"Dumitrescu","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"R20-20260803","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1167\/iovs.10-5392","article-title":"Ophthalmic drug delivery systems for the treatment of retinal diseases:basic research to clinical applications","volume":"51","author":"Edelhauser","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R21-20260803","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/archneur.62.9.1345","article-title":"Characterizing the mechanisms of progression in multiple sclerosis:evidence and new hypotheses for future directions","volume":"62","author":"Frohman","year":"2005","journal-title":"Arch Neurol"},{"key":"R22-20260803","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.2147\/DDDT.S122249","article-title":"Spotlight on siponimod and its potential in the treatment of secondary progressive multiple sclerosis:the evidence to date","volume":"11","author":"Gajofatto","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"R23-20260803","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.exer.2006.09.013","article-title":"Chronic ocular hypertension induces dendrite pathology in the lateral geniculate nucleus of the brain","volume":"84","author":"Gupta","year":"2007","journal-title":"Exp Eye Res"},{"key":"R24-20260803","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.exer.2011.09.023","article-title":"Focus on molecules:sphingosine 1 phosphate (S1P)","volume":"103","author":"Gupta","year":"2012","journal-title":"Exp Eye Res"},{"key":"R25-20260803","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/STROKEAHA.109.568899","article-title":"Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats","volume":"41","author":"Hasegawa","year":"2010","journal-title":"Stroke"},{"key":"R26-20260803","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2174\/1389450116666151001112710","article-title":"Sphingosine-1-phosphate receptors in the central nervous and immune systems","volume":"17","author":"Healy","year":"2016","journal-title":"Curr Drug Targets"},{"key":"R27-20260803","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40263-015-0297-0","article-title":"The direct effects of fingolimod in the central nervous system:implications for relapsing multiple sclerosis","volume":"30","author":"Hunter","year":"2016","journal-title":"CNS Drugs"},{"key":"R28-20260803","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3390\/cells9051108","article-title":"Regulation of microglial functions by purinergic mechanisms in the healthy and diseased CNS","volume":"9","author":"Illes","year":"2020","journal-title":"Cells"},{"key":"R29-20260803","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/jnc.13701","article-title":"Sphingosine 1-phosphate receptor 1 is required for retinal ganglion cell survival after optic nerve trauma","volume":"138","author":"Joly","year":"2016","journal-title":"J Neurochem"},{"key":"R30-20260803","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neurobiolaging.2017.02.004","article-title":"Nonamyloidogenic processing of amyloid beta precursor protein is associated with retinal function improvement in aging male APP(swe)\/PS1\u0394E9 mice","volume":"53","author":"Joly","year":"2017","journal-title":"Neurobiol Aging"},{"key":"R31-20260803","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","article-title":"Glaucoma","volume":"390","author":"Jonas","year":"2017","journal-title":"Lancet"},{"key":"R32-20260803","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/s41433-020-0809-0","article-title":"Advances in ocular drug delivery systems","volume":"34","author":"Kang-Mieler","year":"2020","journal-title":"Eye (Lond)"},{"key":"R33-20260803","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa052643","article-title":"Oral fingolimod (FTY720) for relapsing multiple sclerosis","volume":"355","author":"Kappos","year":"2006","journal-title":"N Engl J Med"},{"key":"R34-20260803","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(18)30475-6","article-title":"Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND):a double-blind randomised phase 3 study","volume":"391","author":"Kappos","year":"2018","journal-title":"Lancet"},{"key":"R35-20260803","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bbamem.2017.03.008","article-title":"Sphingosine 1-phosphate -A double edged sword in the brain","volume":"1859","author":"Karunakaran","year":"2017","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"R36-20260803","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1167\/iovs.02-0398","article-title":"Increase in dephosphorylation of the heavy neurofilament subunit in the monkey chronic glaucoma model","volume":"44","author":"Kashiwagi","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R37-20260803","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/pharmaceutics13010108","article-title":"Ocular drug delivery to the retina:current innovations and future perspectives","volume":"13","author":"Kim","year":"2021","journal-title":"Pharmaceutics"},{"key":"R38-20260803","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.3390\/cells9081771","article-title":"Does siponimod exert direct effects in the central nervous system?","volume":"9","author":"Kipp","year":"2020","journal-title":"Cells"},{"key":"R39-20260803","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrneurol.2012.227","article-title":"The retina as a window to the brain-from eye research to CNS disorders","volume":"9","author":"London","year":"2013","journal-title":"Nat Rev Neurol"},{"issue":"(6)","key":"R40-20260803","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3390\/cells9061515","article-title":"The S1P-S1PR axis in neurological disorders-insights into current and future therapeutic perspectives","volume":"9","author":"Lucaciu","year":"2020","journal-title":"Cells"},{"key":"R41-20260803","first-page":"149","article-title":"Sphingosine-1 phosphate and central nervous system","volume":"378","author":"Martin","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"R42-20260803","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3390\/cells9030535","article-title":"Glaucoma:A degenerative optic neuropathy related to neuroinflammation?","volume":"9","author":"M\u00e9lik Parsadaniantz","year":"2020","journal-title":"Cells"},{"key":"R43-20260803","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1093\/hmg\/ddv218","article-title":"Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation","volume":"24","author":"Miguez","year":"2015","journal-title":"Hum Mol Genet"},{"key":"R44-20260803","doi-asserted-by":"crossref","DOI":"10.1002\/jcb.29822","article-title":"Retinal proteomics of experimental glaucoma model reveal intraocular pressure-induced mediators of neurodegenerative changes","author":"Mirzaei","year":"2020","journal-title":"J Cell Biochem"},{"key":"R45-20260803","doi-asserted-by":"crossref","first-page":"11113","DOI":"10.1128\/MCB.25.24.11113-11121.2005","article-title":"Essential role for sphingosine kinases in neural and vascular development","volume":"25","author":"Mizugishi","year":"2005","journal-title":"Mol Cell Biol"},{"key":"R46-20260803","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neuropharm.2018.02.023","article-title":"Pramipexole and Fingolimod exert neuroprotection in a mouse model of Parkinson's disease by activation of sphingosine kinase 1 and Akt kinase","volume":"135","author":"Motyl","year":"2018","journal-title":"Neuropharmacology"},{"key":"R47-20260803","doi-asserted-by":"crossref","first-page":"12633","DOI":"10.1523\/JNEUROSCI.2801-06.2006","article-title":"Tumor necrosis factor-\u03b1mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma","volume":"26","author":"Nakazawa","year":"2006","journal-title":"J Neurosci"},{"key":"R48-20260803","first-page":"e22925","article-title":"The role of JAK-STAT signaling within the CNS","volume":"2","author":"Nicolas","year":"2013","journal-title":"JAKSTAT"},{"key":"R49-20260803","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2012.12.005","article-title":"Fingolimod phosphate promotes the neuroprotective effects of microglia","volume":"256","author":"Noda","year":"2013","journal-title":"J Neuroimmunol"},{"key":"R50-20260803","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neuropharm.2016.11.006","article-title":"Sphingosine-1-phosphate receptor therapies:advances in clinical trials for CNS-related diseases","volume":"113","author":"O'Sullivan","year":"2017","journal-title":"Neuropharmacology"},{"key":"R51-20260803","doi-asserted-by":"crossref","first-page":"100799","DOI":"10.1016\/j.preteyeres.2019.100799","article-title":"Inducible rodent models of glaucoma","volume":"75","author":"Pang","year":"2020","journal-title":"Prog Retin Eye Res"},{"key":"R52-20260803","doi-asserted-by":"crossref","first-page":"654850","DOI":"10.3389\/fneur.2021.654850","article-title":"Glial purinergic signaling in neurodegeneration","volume":"12","author":"Pietrowski","year":"2021","journal-title":"Front Neurol"},{"key":"R53-20260803","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/molecules22030344","article-title":"Sphingosine 1-phosphate receptor 1 signaling in mammalian cells","volume":"22","author":"Pyne","year":"2017","journal-title":"Molecules"},{"key":"R54-20260803","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1161\/STROKEAHA.117.018505","article-title":"Fingolimod protects against ischemic white matter damage by modulating microglia toward M2 polarization via STAT3 pathway","volume":"48","author":"Qin","year":"2017","journal-title":"Stroke"},{"key":"R55-20260803","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s12640-019-0003-y","article-title":"The role of PI3K\/Akt and ERK in neurodegenerative disorders","volume":"35","author":"Rai","year":"2019","journal-title":"Neurotox Res"},{"key":"R56-20260803","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fnmol.2018.00293","article-title":"Human tau expression does not induce mouse retina neurodegeneration suggesting differential toxicity of tau in brain vs. retinal neurons","volume":"11","author":"Rodriguez","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"R57-20260803","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.3390\/ijms21207537","article-title":"Sphingosine-1-phosphate receptor modulators and oligodendroglial cells:beyond immunomodulation","volume":"21","author":"Roggeri","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R58-20260803","doi-asserted-by":"crossref","first-page":"612422","DOI":"10.3389\/fneur.2020.612422","article-title":"The role of neuroinflammation in glaucoma:an update on molecular mechanisms and new therapeutic options","volume":"11","author":"Rolle","year":"2020","journal-title":"Front Neurol"},{"key":"R59-20260803","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1073\/pnas.1615413114","article-title":"Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation","volume":"114","author":"Rothhammer","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R60-20260803","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ:25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"R61-20260803","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1038\/ncomms5859","article-title":"Hypothalamic S1P\/S1PR1 axis controls energy homeostasis","volume":"5","author":"Silva","year":"2014","journal-title":"Nat Commun"},{"key":"R62-20260803","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11910-021-01110-5","article-title":"Chronic demyelination and axonal degeneration in multiple sclerosis:pathogenesis and therapeutic implications","volume":"21","author":"Simkins","year":"2021","journal-title":"Curr Neurol Neurosci Rep"},{"key":"R63-20260803","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.neuron.2009.11.021","article-title":"SOCS3 deletion promotes optic nerve regeneration in vivo","volume":"64","author":"Smith","year":"2009","journal-title":"Neuron"},{"key":"R64-20260803","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/glia.20962","article-title":"Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss","volume":"58","author":"Son","year":"2010","journal-title":"Glia"},{"key":"R65-20260803","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1167\/iovs.11-8732","article-title":"Transsynaptic retinal degeneration in optic neuropathies:optical coherence tomography study","volume":"53","author":"Sriram","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R66-20260803","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13578-020-00416-0","article-title":"Roles of the PI3K\/AKT\/mTOR signalling pathways in neurodegenerative diseases and tumours","volume":"10","author":"Xu","year":"2020","journal-title":"Cell Biosci"},{"key":"R67-20260803","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8072156","article-title":"Activation of sphingosine 1-phosphate receptor 1 enhances hippocampus neurogenesis in a rat model of traumatic brain injury:an involvement of MEK\/Erk signaling pathway","author":"Ye","year":"2016","journal-title":"Neural Plast"},{"key":"R68-20260803","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1515\/revneuro-2013-0003","article-title":"Optic neuropathies:characteristic features and mechanisms of retinal ganglion cell loss","volume":"24","author":"You","year":"2013","journal-title":"Rev Neurosci"},{"key":"R69-20260803","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1167\/iovs.13-13262","article-title":"FTY720 protects retinal ganglion cells in experimental glaucoma","volume":"55","author":"You","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R70-20260803","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/brain\/awy338","article-title":"Demyelination precedes axonal loss in the transneuronal spread of human neurodegenerative disease","volume":"142","author":"You","year":"2019","journal-title":"Brain"},{"key":"R71-20260803","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0079-6123(08)01132-1","article-title":"Glaucoma of the brain:a disease model for the study of transsynaptic neural degeneration","volume":"173","author":"Y\u00fccel","year":"2008","journal-title":"Prog Brain Res"},{"key":"R72-20260803","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainresbull.2020.08.013","article-title":"FTY720 in CNS injuries:Molecular mechanisms and therapeutic potential","volume":"164","author":"Zhang","year":"2020","journal-title":"Brain Res Bull"},{"key":"R73-20260803","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1096\/fj.201600751r","article-title":"Neuroprotective effects of fingolimod in mouse models of Parkinson's disease","volume":"31","author":"Zhao","year":"2017","journal-title":"FASEB J"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.344952","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:31:00Z","timestamp":1786735860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.344952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/1673-5374.344952","relation":{},"ISSN":["1673-5374","1876-7958"],"issn-type":[{"value":"1673-5374","type":"print"},{"value":"1876-7958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"assertion":[{"value":"2022-01-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}